Intentions Seeker Stocks: Grupo Aeroportuario del Sureste, SAB de CV (NYSE:ASR), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Isis Pharmaceuticals, Inc. (NASDAQ:ISIS)

Grupo Aeroportuario del Sureste, SAB de CV (NYSE:ASR) declared that total passenger traffic for September 2014 increased by 10.5% when compared to September 2013. This declaration reflects comparisons between September 1 through September 30, 2014 and 2013. Grupo Aeroportuario del Sureste, SAB de CV (NYSE:ASR) begun last trade with a price of $134.78 and throughout the trading session climbed at a high of $135.84. The day-trade ended with 0.56% to $135.15. The stock is going forward to its 52 week low with 26.51% and lagging behind from its 52 week high price with -1.99%. ASR last month stock price volatility remained 2.06%.Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) released that the submission of a New Drug apps to the U.S. FDA and a Marketing Authorization Application to the European Medicines Agency for a fully co-formulated combination of lumacaftor as well as ivacaftor for people with cystic fibrosis ages 12 and older who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator gene. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock price closed at $111.59 with the total traded volume of 1.1 Million shares. Its price to sales ratio ended at 34.06. Its market capitalization is 26.350 Billion. The stock owned by the Financial Institutions was 92.20% while by insiders was 0.30%.Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) released that it has earned a $7.5M milestone payment, the first of two milestone payments totaling $15M, from AstraZeneca (AZN) for the advancement of ISIS-STAT3. AstraZeneca is recently evaluating ISIS-STAT3 in a Phase 1/2 clinical study in patients with advanced metastatic liver cancer. AstraZeneca plans to initiate additional clinical studies to further evaluate ISIS-STAT3. Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) has the market capitalization of 5.194 Billion. Shares of firm plunged -3.25% to close at $44.12 with the total traded volume of 1.42 Million. The firm has current ratio of 7.00 for the most recent quarter.